HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: L'Oreal S.A.

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal S.A.: Predicts consolidated net sales growth of 12%-13% in 1995 based "on published figures at current exchange rates." Net sales in 1994 were FFr 47.62 bil. The growth will "reflect the reduced impact of the change in structure on the second half," L'Oreal adds. Overall net sales for the first six months of 1995 rose 6.9% on a comparable basis and 22.8% for the same period based on published figures. L'Oreal attributed the disparity in the growth figures to a 20.6% increase related to changes in how the company structures its subsidiaries structure and a negative exchange difference of 4.7%, reflecting the average decline between the French franc and other currencies. First half operating profit advanced 11.1%...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002186

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel